Tamiflu® Oral Suspension 6mg/ml | Oseltamivir | Influenza Antiviral Treatment | Suitable for Children

HK-62242

Part 1, Schedule 1 & Schedule 3 Poison

Active Ingredient

oseltamivir (as phosphate)

Tamiflu® Oral Suspension is suitable for the following individuals:

• Infants or children with influenza.

Tamiflu® Oral Suspension is not suitable for the following individuals:

• Individuals who are allergic to oseltamivir.
• Individuals with renal impairment.

The golden 48-hour window is a key treatment period for Tamiflu® in influenza management. Treatment should ideally be started within 48 hours from the onset of flu symptoms for optimal effectiveness.

Paediatric Tamiflu® Dosage Guide

• Treatment course: Take continuously for 5 days.
• Prophylaxis course: Take continuously for 10 days.

Infants aged 2 weeks to under 1 year

UseDosageOral Suspension VolumeTreatment3 mg/kg, twice daily0.5 ml/kgProphylaxisNot applicableNot applicable

Note: Infants in this age group require the dedicated oral suspension formulation. One bottle is required.

Children aged 1 to 12 years, by body weight

Body WeightTreatment Dose, Twice DailyProphylaxis Dose, Once DailyOral Suspension VolumeSuggested Number of Bottles≤15 kg30 mg30 mg5 ml1 bottle15.1–23 kg45 mg45 mg7.5 ml2 bottles23.1–40 kg60 mg60 mg10 ml2 bottles≥40.1 kg75 mg75 mg12.5 ml3 bottles

Tamiflu® is a prescription medication and may cause the following common side effects, which are usually mild and often occur during the initial adjustment period:

• Nausea and vomiting
• Headache and dizziness
• Mild discomfort such as insomnia

These symptoms usually occur at the beginning of treatment. As the body adjusts to the medication, symptoms are relieved in most users.

Rare but serious side effects may involve delirium, abnormal behaviour, severe skin reactions or allergic reactions. If side effects occur, especially if the symptoms are severe or persistent, you should consult a doctor.